Aberrant FHIT protein expression in classical Hodgkin's lymphoma: A potential marker

Pathology

Volumn 38, Issue 5, 2006, Pages 399-402

  Zhao, Po ^a   Lam, Alfred King Yin ^b   Lu, Ya Li ^a   Zhong, Mei ^a   Chen, Ling Hong ^a   Pu, Xiao Lu ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

FHIT; Hodgkin's lymphoma; Reed Sternberg cells

Indexed keywords

BIOLOGICAL MARKER; FRAGILE HISTIDINE TRIAD PROTEIN;

ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; DISEASE MARKER; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL DOCUMENTATION; NONHODGKIN LYMPHOMA; PATHOGENESIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REED STERNBERG CELL; SAMPLE SIZE; WESTERN BLOTTING;

ACID ANHYDRIDE HYDROLASES; BLOTTING, WESTERN; FEMALE; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HODGKIN DISEASE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASM PROTEINS; REED-STERNBERG CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 33749188577     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020600922512     Document Type: Article

References (24)

1. Stein H, Delsol G, Pileri S, et al. Classical Hodgkin lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours. Tumours of Haematopoeitic and Lymphoid Tissues. Lyon: IARC Press, 2001; 244-53.
2. Kadin ME. A reappraisal of the Reed-Sternberg cell. A commentary. Blood Cells 1980; 6: 525-32.
3. Kadin ME, Muramoto L, Said J. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease. Am J Pathol 1988; 130: 345-53.
4. Seitz V, Hummei M, Marafioti T, Anagnostopoulos I, Assaf C, Stein H. Detection of clonal T-cell receptor gamma chain gene rearrangements in Reed-Sternberg cells of classical Hodgkin disease. Blood 2000; 95: 3020-4.
5. Marafioti T, Hummel M, Foss HD, et al. Hodgkin's and Reed-Sternberg cell represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000; 95: 1443-50.
6. Chang KL, Albujar PF, Chen YY, Johnson RM, Weiss LM. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood 1993; 81: 496-501.
7. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991; 337: 320-2.
8. Weiss LM, Chen YY, Liu XF, Shibata D. Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 1991; 139: 1259-65.
9. Ishii H, Ozawa K, Furukawa Y. Alteration of the fragile histidine triad gene early in carcinogenesis: an update. J Exp Ther Oncol 2003; 3: 291-6.
10. Croce CM, Sozzi G, Huebner K. Role of FHIT in human cancer. J Clin Oncol 1999; 17: 1618-24.
11. Huebner K, Croce CM. Cancer and the FRA3B/FHIT fragile locus: it's a HIT. Br J Cancer 2003; 88: 1501-6.
12. Zhao P, Song X, Nin YY, Lu YL, Li XH. Loss of fragile histidine triad protein in human hepatocellular carcinoma. World J Gastroenterol 2003; 9: 1216-9.
13. Ishii H, Furukawa Y. Alterations of common chromosome fragile sites in hematopoietic malignancies. Int J Hematol 2004; 79: 238-42.
14. Kameoka Y, Tagawa H, Tsuzuki S, et al. Contig array CGH at 3p14.2 points to the FRA3B/FHIT common fragile region as the target gene in diffuse large B-cell lymphoma. Oncogene 2004; 23: 9148-54.
15. Chen PM, Yang MH, Hsiao LT, et al. Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphoma. Oncol Rep 2004; 11: 349-56.
16. Ferrer M, Lopez-Borges S, Lazo PA. Expression of aberrant functional and nonfunctional transcripts of the FHIT gene in Burkitt's lymphomas. Mol Carcinog 1999; 25: 55-63.
17. Hussain A, Gutierrez MI, Timson G, et al. Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation. Genes Chromosomes Cancer 2004; 41: 321-9.
18. Takada S, Morita K, Hayashi K, et al. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with multiple myeloma. Eur J Haematol 2005; 75: 505-10.
19. Hallas C, Albitar M, Letofsky J, Keating MJ, Huebner K, Croce CM. Loss of FHIT expression in acute lymphoblastic leukemia. Clin Cancer Res 1999; 5: 2409-14.
20. Luan X, Ramesh KH, Cannizzaro LA. FHIT gene transcript alterations occur frequently in myeloproliferative and myelodysplastic diseases. Cytogenet Cell Genet 1998; 81: 183-8.
21. Pinkus GS, Pinkus JL, Langhoff E, et al. Fascin, a sensitive new marker for Reed-Sternberg cells of Hodgkin's desease: evidence for dendritic or B cell derivation? Am J Pathol 1997; 150: 543-62.
22. Nakamura S, Nagahama M, Kagami Y, et al. Hodgkin's disease expressing follicular dendritic cell marker CD21 without any other B-cell marker; a clinicopathologic study of nine cases. Am J Surg Pathol 1999; 23: 363-76.
23. Wetzler M, Talpaz M, Van Etten RA, Hirsh-Ginsberg C, Beran M, Kurzrock R. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J Clin Invest 1993; 92: 1925-39.
24. Golebiowski F, Kowara R, Pawelczyk T. Distribution of Fhit protein in rat tissues and its intracellular localization. Mol Cell Biochem 2001; 226: 49-55.